Cholesterol-rich lipid rafts as platforms for SARS-CoV-2 entry
SN Palacios-Rapalo, LA De Jesus-Gonzalez… - Frontiers in …, 2021 - frontiersin.org
Since its appearance, the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2),
the causal agent of Coronavirus Disease 2019 (COVID-19), represents a global problem for …
the causal agent of Coronavirus Disease 2019 (COVID-19), represents a global problem for …
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
S Das, SS Kar, S Samanta, J Banerjee, B Giri… - Immunologic …, 2022 - Springer
SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …
Prospective roles of tumor necrosis factor-alpha (TNF-α) in COVID-19: prognosis, therapeutic and management
Z Mohd Zawawi, J Kalyanasundram… - International journal of …, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) became a worldwide concern at the beginning of
2020 and has affected millions. Several previous studies revealed the impact of the …
2020 and has affected millions. Several previous studies revealed the impact of the …
SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways
J Deng, SN Zheng, Y Xiao, ML Nan… - Journal of Medical …, 2023 - Wiley Online Library
SARS‐CoV‐2 has developed a variety of approaches to counteract host innate antiviral
immunity to facilitate its infection, replication and pathogenesis, but the molecular …
immunity to facilitate its infection, replication and pathogenesis, but the molecular …
SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways
J Deng, Y Zheng, SN Zheng, ML Nan… - Journal of Medical …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a poor inducer of innate
antiviral immunity, and the underlying mechanism still needs further investigation. Here, we …
antiviral immunity, and the underlying mechanism still needs further investigation. Here, we …
Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis
F Jiang, Y Liu, Y Xue, P Cheng, J Wang, J Lian… - International …, 2023 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
monkeypox virus (MPXV) severely threaten human health; however, currently, no vaccine …
monkeypox virus (MPXV) severely threaten human health; however, currently, no vaccine …
Zooming in on common immune evasion mechanisms of pathogens in phagolysosomes: potential broad-spectrum therapeutic targets against infectious diseases
The intracellular viral, bacterial, or parasitic pathogens evade the host immune challenges to
propagate and cause fatal diseases. The microbes overpower host immunity at various …
propagate and cause fatal diseases. The microbes overpower host immunity at various …
[HTML][HTML] Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
CA Labarrere, GS Kassab - Frontiers in Microbiology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …
[HTML][HTML] SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases
R Larionova, K Byvaltsev, О Kravtsova, E Takha… - Journal of Translational …, 2022 - Elsevier
The clinical and immunological spectrum of acute and post-active COVID-19 syndrome
overlaps with criteria used to characterize autoimmune diseases such as rheumatoid …
overlaps with criteria used to characterize autoimmune diseases such as rheumatoid …
Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll‐like receptors dictates pathophysiology of COVID‐19 disease
MK Vakil, Y Mansoori, GRL Al‐Awsi… - Journal of Medical …, 2022 - Wiley Online Library
Innate and acquired immunity responses are crucial for viral infection elimination. However,
genetic variations in coding genes may exacerbate the inflammation or initiate devastating …
genetic variations in coding genes may exacerbate the inflammation or initiate devastating …